Ovaries from National Toxicology Program Reproductive Assessment by Continuous Breeding (RACB) bioassays were used to directly compare differential ovarian follicle counts and reproductive performance for 15 chemicals. Ovaries of 10 animals per group from 16 studies in CD-I .mice and 1 study each in C3H and C57BL/ 6 mice were sectioned serially at 6 /xm. Counts of small, growing, and antral follicles were obtained in every 10th section. For all follicle types, younger mice had more follicles than older mice, and CD-I mice had more follicles than age-matched animals from either inbred strain. The in-life portion of the RACB protocols demonstrated that 9 of 15 chemicals altered reproductive outcome in one or both sexes of mice, with six agents affecting females (R. E. Morrissey et al., 1989, Fundam. AppL Toxicol 13,747-777). Three of six female toxicants [2,2-bis(bromoethyl)-l,3-propanediol, BPD; ethylene glycol monomethyl ether, EGME; methoxyacetic acid, MAA] significantly decreased counts of small and/or growing follicles by 33 to 92% in CD-I mice; EGME also reduced follicle counts in the other strains. Follicle counts were decreased in progeny of animals treated with EGME or its active metabolite, MAA. For BPD, reductions in follicle numbers were proportional to dose. In CD-I mice, female toxicants di-N-hexyl phthalate, propantheline bromide, and tricresyl phosphate reduced reproductive performance but not follicle numbers. Counts were not affected by toxicants for which the susceptible sex could not be determined (bisphenol A, ethylene glycol, oxalic acid). Altered follicle counts without apparent reproductive impairment oc-' To whom correspondence should be sent at current address: Amgen,
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2 To whom reprint requests should be addressed at PAJ-NCTR, P. curred in CD-I mice at lower doses of BPD but were not observed for nontoxic chemicals. These data suggest that differential follicle counts (1) are a quantifiable endpoint of ovarian injury in conventional bioassays, and (2) in some instances, may provide a more sensitive indicator of female reproductive toxicity than fertility.
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Reproductive and developmental toxicity studies are significant components of the regulatory approval process for chemicals and drugs. Reproductive function in both males and females is vulnerable to toxic effects of many teratogens, mutagens, and carcinogens . Sperm morphology and sperm motility data provide good indices of male reproductive toxicity (e.g., Morrissey et al, 1989) . These two tests are readily obtained (repeatedly if needed) and quantified. In contrast, few easily obtainable and quantifiable morphological markers are available to assess female reproductive toxicity. Instead, qualitative measures of reproductive toxicity are often used in females, including reduced fertility or abnormal clinical signs (e.g., weight loss) in the dam or altered reproductive outcome (e.g., embryotoxicity, terata) in the conceptus.
The relationship between female fertility and ovarian follicle development is well recognized (Takizawa and Mattison, 1983) . However, it has been reported that fertility is one of the least sensitive endpoints of reproductive toxicity in laboratory animals (Schwetz et al, 1980) . Studies in mice Takizawa et al., 1984; Weitzman et al, 1992) and rats (Toaff et al, 1979; Flaws et al, 1994) suggest that differentia] follicle counts may provide a sensitive means of estimating the extent of ovarian toxicity in females exposed to xenobiotics. As reported in a preliminary study , a threestage classification system based on follicle diameter and structure (Pedersen and Peters, 1968 , as adapted by Mattison and Nightingale, 1982) appears to provide a quantifiable screening procedure for use in subchronic toxicity bioassays. To relate ovarian response to reproductive performance, both the preliminary and the present studies were carried out using ovaries from rodents in NTP 5 RACB studies (Morrissey et al., 1989) . This unique design allows direct comparison of reproductive outcome and ovarian follicle populations in the same groups of animals. The objective of the current work was to compare reproductive performance and group mean differential follicle counts as endpoints for ovarian toxicity. Our hypothesis was that differential follicle counts would provide, at least in some instances, a more quantifiable, objective, and sensitive estimate of chemically induced ovarian toxicity than functional (e.g., fertility) and gross morphological (e.g., fetal body weight) tests.
MATERIALS AND METHODS
General design of reproductive assessment by continual breeding studies. A specific format for RACB studies has been reported Morrissey et al., 1989) . Briefly, the standard RACB protocol consists of several sequential tasks. After an initial dose-setting study (Task 1) is performed, the continuous breeding phase (Task 2) includes control (n = 40 animals/sex) and up to three treatment groups (n = 20 animals/sex). In Task 2, rodents in the F o (parental) generation are exposed to a chemical during a 7-day premating period, randomly assigned to a mating pair, and then treated with the same chemical and dose throughout a 98-day period of continual cohabitation (during which multiple litters are bom). In early pregnancies, neonates are removed from the dam within 12 hr to encourage immediate remating. The principal measure of toxicity in Task 2 is aberrant reproductive performance in F o rodents as indicated by alterations in the number of litters per breeding pair, the number of live pups per litter, or neonatal body weight and sex ratio. Breeding pairs are separated after 98 days, but treatment is continued for both sire and dam until this final litter (the F| generation) is delivered and weaned. The F| offspring are then dosed (Task 4) until 74 ± 10 days of age, at which time male and female animals from the same treatment group but different litters are mated (n = 20/sex/ group) to generate F 2 litters. If reproductive outcome of parent animals is altered in the Task 2 continuous breeding phase (i.e., a "positive" toxicity study), a crossover mating trial (Task 3) is performed to determine whether males or females are more sensitive. For this phase, high-dose F o animals of each sex are paired to F o control mice of the opposite sex, and reproductive performance is compared to matings between control F o males and control F o females (using parameters listed above for Task 2) to determine the affected sex(es). Crossover mating is omitted if the Task 2 continuous breeding phase in F o parents is not associated with reproductive alterations (i.e., a "negative" study).
Thus, Task 2 and Task 3 employ the same F o parents, with Task 3 resulting in an additional period of chemical exposure. Task 4 animals are Fi offspring of Task 2 parents and have therefore been exposed to the test material as gametes, during prenatal and postnatal development, and as young adults.
3 Abbreviations used: AA, 9-aminoacridine; BA, bisphenol A; BPD, 2,2-bis (bromoethy])-l,3-propanediol; EG, ethylene glycol; EGME, ethylene glycol monomethyl ether, ETH, ethanol; MAA, methoxyacetic acid; MTD, maximum tolerated dose; NHP, di-AMiexyl phthalate; NTP, National Toxicology Program; OA, oxalic acid; PB, propantheline bromide; PG, propylene glycol; PGME, propylene glycol monomethyl ether, RACB, Reproductive Assessment by Continuous Breeding; TCE, trichloroethylene; TCP, tricresyl phosphate; TGD, triethylene glycol diacetate.
Experimental design. For the present retrospective study, ovaries from mice exposed to chemicals in 18 RACB bioassays assessing the reproductive toxicity of 15 chemicals were obtained from the NTP archive to relate changes in ovarian morphology to impaired reproductive performance. Outbred Crl:CD-l (ICR)BR Swiss albino (CD-I) mice were used for 16 studies. Four of the bioassays compared the effects of EGME, a positive control agent that markedly reduces reproductive function in many species including mice (Andrews and Snyder, 1986) , in three mouse strains (CD-I, C3H, C57BL/6). A partial listing of reproductive outcomes from these RACB studies has been published (Morrissey et ai, 1989) . 6 These studies had been conducted according to U.S. FDA Good Laboratory Practice guidelines over a 3-year period at two independent contract toxicology laboratories. Ovaries of both control and treated animals were evaluated for all but one of the bioassays (a Task 2 study with EGME in C3H mice).
These 18 bioassays provided the necessary positive and negative data sets to test our hypothesis. Of the 15 agents tested, 6 (9AA, ETH, PG, PGME, TCE, TCP) had no effect on reproductive function, while 9 significantly altered the reproductive outcome relative to appropriate controls (Morrissey et al., 1989) . Crossover mating trials revealed that 5 toxicants (EGME, MAA, NHP, PB, TCP) altered reproductive performance of both males and females while 1 (BPD) affected only females. The crossover mating trials could not determine the affected sex for three additional toxicants (BA, EG, OA) (Morrissey et al., 1989) . Reproductive performance was known prior to histopathological analysis.
Tissue Processing. Ovaries from one Task 1 dose range-finding experiment (approximately 50 days old), F o parents from negative Task 2 continuous breeding studies (approximately 215 days old), F o parents from Task 3 crossover mating trials (approximately 240 days old), or F, offspring (approximately 120 days old) from Task 4 were removed at necropsy, trimmed of fat, fixed by immersion in Bouin's solution for 12 to 24 hr, and then transferred to 70% ethanol for storage and transport. Intact ovaries from each animal were dehydrated in graded alcohols and xylene and then embedded in a longitudinal orientation in separate paraffin blocks; one ovary per animal was sectioned serially at 6 fun. Two rows of five sections retained in sequence were applied to each slide, and sections were stained with hematoxylin and eosin. Each ovary yielded approximately 400 sections (40 slides).
Selection of ovarian sections. With few exceptions, counts were gathered for ovaries from 10 mice per group. Ovaries were available from only 5 to 6 treated animals in F, offspring from two Task 4 EGME assays and from 9 treated animals from the Task 2 oxalic acid study. For these limited cohorts, ovaries were chosen at random from untreated animals of the same studies to produce an equal number of control tissues for analysis.
Sections from each ovary were examined in order beginning with the first section of the first slide (i.e., the most superficial layer of the lateral capsule). Typically, follicles were not encountered until at least the third or fourth section (i.e., a distance of 18 to 24 fim into the ovary). These follicles were categorized and enumerated. Differential counts were then made from every 10th section (e.g., the third or fourth sections of all other slides), or from approximately 40 sections per ovary. This procedure provided a nonrandom 10% sample, with each counted section separated by a distance of approximately 60 fim.
Method for ovarian foliicular differential counts. In the present work, three classes of ovarian follicles (illustrated in Fig. 1 ) were categorized using (a) the relative cross-sectional diameter of the follicle as measured from the outer margins of the granulosa cell layers, (b) the number of granulosa cell layers, and (c) the nature of the antral space. These qualitative criteria represent a substantial simplification of an elaborate grading system (proposed by Pedersen and Peters, 1968 ) that uses eight stages and several substages to differentiate between primordial oocytes (Type 1) to antral follicles (Type 8).
"Small" follicles (Pedersen and Peters Types 1 -3b) consisted of an isolated oocyte or an oocyte surrounded by a partial or unbroken, single layer of granulosa cells (Fig. 1) . "Growing" follicles (Pedersen and Peters Types 4-5b) had an oocyte surrounded by a multilayered, solid mantle of granulosa cells (Fig. 1) . "Antral" follicles (Pedersen and Peters Types 6-8) were characterized by a central oocyte and fluid-filled space bordered by hundreds of layered granulosa cells. Using these criteria, mean diameters have been measured at approximately 20 /*m for small, 20 to 70 /*m for growing, and more than 70 /im for antral follicles in mice (Pedersen and Peters, 1968) .
Differential follicle counts were performed by five experienced histotechnicians. Follicle counts were generated manually on a multiregistered cell counter (Clay-Adams, Parsippany, NJ). Each technician counted ovaries that they had sectioned. Replicate differential counts were performed on each ovary by a second technician to evaluate interobserver reproducibility. Each counting session was limited to no more than 3 hr to limit fatigue. Data processing. Differential counts were collated and analyzed by a modular Ovarian Toxicology Data Management Program developed specifically for this project Input parameters allowed entry of protocol characteristics (e.g., study number, chemical, dose, species, individual animal numbers, ovarian weight), technician identification, and differential counts (by follicle class) for each ovarian section. A randomized selection of ovaries to be processed and counted was generated from these input parameters. Output (presented in fixed-format reports) included individual animal and group totals, means, and standard deviations from individual or all technicians. Built-in safeguards (e.g., flags on "out-lying" ovarian follicle counts) to ensure proper data input and verification as well as an automatic audit trail for all original and corrected entries were cardinal features of this program.
For each animal, counts from the cell counter register were transferred manually to a worksheet These data were entered manually into a computer database. The integrity of data transfer was validated by a single operator (A. Warbritton).
Statistical analysis.
Mean differentia] counts for each follicle class in a group were compared for overall differences to the appropriate follicle class in other animals from the same study using the Kruskal-Wallis nonparametric ANOVA. Where present, significant dose-response trends were then tested pairwise using the Mann-Whitney U test to determine the affected treatment group(s). All comparisons were two sided. The significance level for these analyses was set at p « 0.05.
RESULTS

Normal Differential Counts in Control Mice of Various Strains
The means for the various ovarian follicle classes are listed in Tables 1 and 2 for control mice of different ages and strains. As expected, small and growing follicles were 10-to 20-fold more numerous than antral follicles in all strains. In addition, CD-I mice at all ages had more follicles of all classes than did either C3H or C57BL/6 mice. For individual animals, the mean number of small follicles ranged from 30 to 560 (above 130 in 94% of mice), while counts of growing follicles ranged from 20 to 134 (above 50 in 88%). In general, the means for these two classes of follicles in F, mice (117 ± 10 days old) were approximately double those measured in 240-day-old F o parents. These data are comparable to counts reported previously for age- Antral 7 ± 4 2 ± 2 6 ± 3 2 ± 2 9 ± 6 9 ± 3 7 + 3 4 ± 4 12 ± 8 11 ± 6 8 ± 4 7 + 5 Values represent mean counts (± standard deviation) based on a 10% nonrandom sample (every 10th serial section) from one ovary of each of 10 animals per treatment group. matched control mice from the Bagg (Pedersen, 1972) , B6C3F1 (Smith et al, 1991) , C57BL/6N (Takizawa et al, 1984; Smith et al, 1991) , and DBA/2N (Takizawa et al, 1984) strains.
The variation in follicle counts between untreated mice from a given study (n = 10 per control group) was striking (Table 1) . For individual animals, counts of small and growing follicles deviated from the mean by between 19 to 41% for 117-day-old animals. In like manner, counts of small and growing follicles differed from the mean by 26 to 72% for mice over 200 days old. The average divergence at 117 days was 30% for both follicle classes, while that in older mice was 46% for small follicles and 40% for growing follicles. Considerable variation in differential follicle counts also was observed within the CD-I strain between control groups of the same age but from different studies ( Table 1 ). The difference was most pronounced in the small follicle class, where the divergence between the lowest and highest mean counts ranged from 40 to 50%; these differences were not statistically significant. The mean counts for the different observers from the same sets of ovaries were similar (Table 3) . For both control and chemically treated ovaries, the variation between pairs of technicians ranged from 0 to 30%, with a median variance of approximately 8% for counts of small follicles and 15% for growing follicles (data not shown). Mean counts between individuals were not statistically significant.
Chemically Induced Alterations in Differential Follicle Counts
As in control animals, small and growing follicles were more numerous than larger antral ones in treated mice (Table   4) . Similarly, mean counts for these two classes of follicles were twofold higher in 117-day-old F, animals (Task 4) than in 240-day-old F o parents (Task 3). Of the six chemicals that induced toxicity in females, three (BPD, EGME, MAA) caused statistically significant reductions in the mean follicle numbers of one or more size categories (Table 4 ). Relative to age-matched control animals, the extent of these reductions ranged from 33 to 92%. Follicle reduction was proportional to dose for Task 4 (F,) animals exposed to BPD. Two compounds, EGME and its active metabolite, MAA, reduced follicle counts only in the F, generation. Follicle counts were not reduced in the absence of reproductive impairment for nontoxic chemicals (i.e., no false positives). However, follicle counts were reduced in Task 4 (F,) offspring by lower doses of the toxicant BPD for which altered reproductive performance had not been reported. Follicle numbers were not reduced for the female toxicants NHP, PB, and TCP nor for RACB toxicants for which a specific affected sex could not be determined in Task 3 (BA, EG, OA). Thus, the possibility exists for false negatives using this technique. Table  5 shows the association between reproductive performance and the ovarian follicle differential counts.
DISCUSSION
One weakness in the design of conventional reproductive toxicity bioassays is the paucity of markers for quantifying female-specific effects of xenobiotics. The RACB design employed for the current work tests the integrated response of the reproductive system to chemical exposure throughout all prenatal and postnatal critical periods of reproductive tract development. However, RACB endpoints provide im- 92 ± 32 81 ± 26 62 ± 25 15 ± 12' 101 ± 27 80 ± 34 56 ± 23" 27 ± 18" 5 ± 7 ± 5 ± 5 ± 4 ± 2 ± 4 ± 6± 6 ± 5 ± 7 ± 6 ± 4 ± 2 ± 3 ± 5 ± 4 ± 2 ± 3 ± 12 ± 6 ± 4 ± 3 ± 2 ± 3 ± 2 ± 1 ± 2 ± 2 ± 6 ± 4 ± 20 ± 11 ± 3 ± 2 ± 2 ± 2 ± 15 ± 12 ± 13 ± 15 ± 3 ± 4 ± 5 ± 5 ± 7 ± 2 ± 10 ± 10 ± 7 ± 5 ± Antral 8 ± 5 ± 5 ± 5 ± 7 ± 5 ± 9 ± 9± 8 ± 7 ± 6 ± 5 ± 4 ± 6± 7 ± 2 ± 1 ± 5± 3± 3 ± 2 ± 5 ± 5 ± 4 ± Note. N, no toxicity; Y, toxicity supported by RACB data; Y*, toxicity interpolated from RACB data; NR, not reported.° Denotes altered reproductive outcome based on published RACB test results (Morrissey et al, 1989) . * Values represent mean counts (± standard deviation) based on a 10% nonrandom sample (every 10th serial section) from one ovary of each of 10 animals per treatment group (except as noted in Table 2 ).
c Denotes a significant difference from controls by the Mann-Whitney U test, p s 0.05. d Denotes a significance between dose groups by the Kruskal-Wallis nonparametric ANOVA, p rs 0.05. precise (if any) estimates of target tissue(s) or toxic mechanisms. Thus, the present study investigated ovarian follicle differential counts as a quantifiable, morphological marker of ovarian toxicity to augment the more qualitative data derived from RACB assays. In addition, follicle counts would significantly enhance the information gained from conventional subchronic and chronic studies (which rely on histopathological rather than functional endpoints of toxicity) because changes in follicle number would suggest the possibility of an ovarian functional deficit. Differential follicle counts could be obtained with only minor changes to the current ovarian sampling process and without increasing the number of females allocated to dose groups. The current data revealed an association between reduced numbers of small and growing follicles and reproductive impairment for three of six female-specific toxicants. Ovarian follicle loss was induced in F, (Task 4) mice by three chemicals, while only one agent reduced counts in F o (Task 2 or 3) animals. It should be noted that one toxicant was not studied in F! mice, so the success rate of differential follicle counts in detecting ovarian damage in young animals might be higher.
Numbers of small and growing follicles were found to be the best markers for quantifying damage. Relative to other ovarian structures (antral follicles and corpora lutea), small and growing follicles are 10-to 20-fold more numerous, are relatively unaffected by hormonal fluctuations during estrus and rarely undergo spontaneous atresia (Pedersen, 1970 (Pedersen, , 1972 . Furthermore, these two follicle classes represent the maturation pool of female gametes, thus providing a direct estimate of ovarian functional reserve following xenobiotic exposure. The stability of small and growing follicle populations was critical for statistical analysis because the standard deviation from the mean for follicle count data in control animals averaged 30% for younger mice and approached 50% for older individuals. Given the present results, it would seem to be prudent (and cost effective) in a multigeneration bioassay to initially obtain differential follicle counts only in ovaries from Task 4 (F,) animals.
In this study, follicle counts provided, at least in one case, a more sensitive indicator of potential toxicity than did measures of fertility. For example, reduced differential follicle counts without apparent reproductive impairment occurred in CD-I mice at low doses of BPD but were not observed for nontoxic chemicals (i.e., no false positives). Presumably, the premature loss of ovarian follicles would have resulted in premature reproductive senescence in these mice if the RACB trials had been extended, a situation comparable to that documented in women given cytotoxic agents (Chapman et al, 1979) and postulated for women smokers based on epidemiologic studies that link smoking to infertility (Howe et al, 1985) and early menopause (Jick et al, 1977) . Nevertheless, half of the toxicants that altered one or more functional endpoints of reproductive outcome during the RACB bioassays (Morrissey et al, 1989 ) had no effect on differential follicle counts (i.e., some false negatives). This finding was expected because certain agents will induce biochemical (functional) ovarian toxicity that is not reflected morphologically (Richards, 1986; Mattison and Thomford, 1989 ). Another explanation for the discrepancy between functional and morphological findings could be the presence of end-organ reproductive toxicity at an extraovarian target site such as the neuroendocrine brain, peripheral nervous system, oviduct, uterus, cervix, or accessory sex glands McLachlan and Newbold, 1989) . In short, these facts indicate that measurement of ovarian follicle numbers would not be a sensitive "stand alone" screen but would be more appropriate as one means of defining the toxic mechanism.
Significant qualitative concordance in the extent of ovarian damage exists between animal studies and human clinical experience for a few chemicals , indicating that follicle differential counts may have utility for interspecies extrapolation. For example, several agents destroy primordial follicles in mice (Mody, 1960; Mattison and Thorgeirsson, 1978) in an age- (Felton and Dobson, 1978; Mattison and Thomford, 1989 ) and strain- (Godowicz and Paulus, 1985) dependent manner. In like manner, ovarian failure resulting from primordial follicle depletion has been reported in women given multiple cycles of antineoplastic drugs, chiefly the MVPP regimen (mechlorethamine HC1, vinblastine sulfate, procarbazine HC1, prednisolone; Chapman et al., 1979) . Toxic effects of chemicals seem to be more pronounced in older than younger women , an age dependency that was the reverse of mice in the present study (in which two of three female toxicants selectively affected younger mice). However, it should be noted that in addition to chemical treatment during adulthood, mice in the RACB studies were exposed during prenatal and early postnatal development when follicles are more susceptible to toxicants than in the adult . Given the relative resistance of human primordial follicles in comparison to rodents (Wallace et al, 1989) , it is apparent that further work will be required to evaluate whether or not human and murine follicle counts respond in a comparable fashion to reproductive toxicants.
One unexpected finding in the present work was the large variation in differential follicle counts between control mice from different strains. Both C3H and C57BL/6 mice are less fecund than CD-I mice (Chapin et al, 1993) . In the present analysis, these two inbred strains had three-to fourfold fewer follicles of each class than did age-matched CD-I mice. These data suggest a possible correlation between follicle numbers, basal reproductive performance, and ovarian vulnerability to toxicants. When treated with EGME using the RACB protocol (Chapin et al., 1993) , fertility in these three mouse strains decreased in the order CD-I > C57BL/6 > C3H, while their toxic response (based on reduced numbers of live pups) to EGME exposure was C3H > C57BL/6 > CD-I. Ovarian weight changes were absent in EGME-treated F o mice from all strains (Chapin et al., 1993) , a finding which matches the present data in that EGME had no effect on ovarian follicle numbers in the parental generations of these mouse strains. In contrast, in the F, progeny ovarian weights were unaltered (Chapin et al, 1993) even though there were significant deficits in the numbers of small and growing follicles from all three strains. This latter finding indicates that differential follicle counts are likely to be more sensitive measures of chemically induced ovarian toxicity than are gross ovarian weights.
Another significant finding in the present work was the considerable variability in differential follicle counts between control CD-I mice from different RACB bioassays. Counts of small follicles in F, offspring (Task 4) varied by as much as twofold even though they were within the range of 400 to 550 in 7 of 10 RACB studies. The reason for this variability is unclear. Low follicle counts could conceivably have resulted from submission of incomplete ovaries. However, all specimens appeared intact upon visual inspection, and the same number of sections (approximately 400) were cut from most tissues. Interobserver variability in acquiring differential counts was another potential reason. This explanation was rejected because the difference in counts between technicians (8 to 15%) was too small to explain the degree of variability. Furthermore, mean follicle numbers for control and treatment groups were in the same range within a given RACB study but not between studies, suggesting the influence of study-or animal-specific factors on follicle populations. External factors including photoperiod, temperature, population density, and diet may influence reproductive processes in mice (Whittingham and Wood, 1983) ; thus, environmental differences between the two contract laboratories that performed these RACB studies conceivably could have affected follicle counts. However, the use of GLP guidelines presumably minimized fluctuations both within and between these breeding facilities. Therefore, interindividual differences in follicle numbers were considered as the most likely possibility. Mice lose follicles at different rates (Jones and Krohn, 1961) , resulting in follicle numbers for young adults ranging from tens to a few hundred (Takizawaetal., 1984; Smithetal, 1991) . Similarly, considerable variability in follicle number between women of the same age (Block, 1952; Baker, 1963) as well as an eightfold difference in primordial follicle number between age-matched rhesus monkeys (Koering et al., 1991) has been reported. The wide range of follicle counts between individuals of other mouse strains and other species suggests that this is the likely explanation for marked differences in follicle number noted in control CD-I mice in the current study. As shown in our preliminary study , this variability in follicle counts results in a need for a change in the number of small or growing follicles of between 39 to 47% to detect a significant toxicant-induced change (p « 0.05).
Further refinements to the sampling procedure could decrease the cost and time required to perform follicle counts as a toxicity screening. For example, the ovary could be divided and embedded in halves or quarters so that the entire tissue could be serially sectioned in fewer strokes and with fewer slides. Another innovation could be the use of automated image analysis systems to speed counting. Finally, it seems likely that counts could be performed more rapidly if the small and growing follicle classes were combined rather than differentiated. Further work will be required to assess these strategies as a means of improving the data acquisition process.
